Related Experiment Video
Updated: Apr 22, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Thrombosis: a major contributor to the global disease burden
Insights
Venous thromboembolism (VTE) causes a significant global disease burden, particularly in hospitalized patients. More data is needed to inform policies and reduce VTE
Area of Science:
- Epidemiology
- Public Health
Background:
- Thrombosis, including venous thromboembolism (VTE), is a major cause of death and disability.
- Previous studies have not fully captured the global burden of VTE.
Purpose of the Study:
- To systematically review the global disease burden of VTE across different income countries.
- To inform policy and resource allocation for VTE prevention and management.
Main Methods:
- Systematic literature review on the global disease burden of VTE.
- Analysis of incidence rates and disability-adjusted life-years (DALYs) lost.
Main Results:
- Consistent VTE incidence rates (0.75-2.69 per 1000) found in high-income regions, increasing with age.
- VTE is a leading cause of DALYs lost in low- and middle-income countries, and second in high-income countries.
- Population aging in Asian ethnicities contributes to a significant VTE burden despite lower incidence.
Conclusions:
- VTE represents a substantial global health burden across all income levels.
- Further data collection on VTE is crucial for effective health policy and resource allocation.
- Optimizing preventive measures may reduce the overall burden of VTE.
Abstract:
Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2010 documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden caused by VTE in low-income, middle-income and high-income countries. Studies from western Europe, North America, Australia and southern Latin America (Argentina) yielded consistent results, with annual incidence rates ranging from 0.75 to 2.69 per 1000 individuals in the population. The incidence increased to between 2 and 7 per 1000 among those aged ≥ 70 years. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low, because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted life-years (DALYs) lost in low-income and middle-income countries, and the second most common cause in high-income countries, being responsible for more DALYs lost than nosocomial pneumonia, catheter-related bloodstream infections, and adverse drug events. VTE causes a major burden of disease across low-income, middle-income and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate whether improved utilization of preventive measures will reduce the burden.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins

